| 9 |
Estrogen-related receptor γ (ERRγ) is a novel transcriptional regulator of phosphatidic acid phosphatase, LIPIN1, and inhibits hepatic insulin signaling. |
J Biol Chem |
Kim DK, Kim JR, Koh M, Kim YD, Lee JM, Chanda D, Park SB, Min JJ, Lee CH, Park TS, Choi HS |
286(44):38035-42. |
|
| 8 |
Simultaneous uptake of I-131 and F-18 FDG by a renal metastasis of thyroid papillary cancer. |
Clin Nucl Med |
Oh JR, Lim JH, Jeong SY, Heo SH, Chong A, Min JJ. |
36(9):798-9. |
|
| 7 |
Impact of lymphoidfFollicles and histiocytes on the false-positive FDG uptake of lymph nodes in non-small cell lung cancer. |
Nucl Med Mol Imaging |
Kwon SY, Min JJ, Song HC, Choi C, Na KJ, Bom HS. |
45(3):185-91. |
|
| 6 |
The clinical usefulness of F-18 FDG PET/CT in patients with systemic autoimmune disease. |
Nucl Med Mol Imaging |
Oh JR, Song HC, Kang SR, Yoo SW, Kim J, Chong A, Min JJ, Bom HS, Lee SS, Park YW. |
45(3):177-84. |
|
| 5 |
Comparison of ¹³¹I whole-body imaging, ¹³¹I SPECT/CT, and ¹⁸F-FDG PET/CT in the detection of metastatic thyroid cancer. |
Eur J Nucl Med Mol Imaging |
Oh JR, Byun BH, Hong SP, Chong A, Kim J, Yoo SW, Kang SR, Kim DY, Song HC, Bom HS, Min JJ |
38(8):1459-68. |
|
| 4 |
Prognostic significance of interim ¹⁸F-FDG PET/CT after three or four cycles of R-CHOP chemotherapy in the treatment of diffuse large B-cell lymphoma. |
Eur J Cancer |
Yang DH, Min JJ, Song HC, Jeong YY, Chung WK, Bae SY, Ahn JS, Kim YK, Bom HS, Chung IJ, Kim HJ, Lee JJ |
47(9):1312-8. |
|
| 3 |
Engineering and visualization of bacteria for targeting infarcted myocardium. |
Mol Ther |
Le UN, Kim HS, Kwon JS, Kim MY, Nguyen VH, Jiang SN, Lee BI, Hong Y, Shin MG, Rhee JH, Bom HS, Ahn Y, Gambhir SS, Choy HE, Min JJ |
19(5):951-9. |
|
| 2 |
Gene therapy for head and neck squamous cell carcinoma using KITENIN (KAI1 COOH-Terminal Interacting Tetraspanin)-antisense therapy. |
Yonsei Med J |
Lee JK, Lee DH, Sun EG, Bae JA, Lim SC, Min JJ, Sung MW, Kim KK |
52(3):463-8. |
|
| 1 |
A Case of Disseminated and Fulminant Plasmacytomas That Developed during Bortezomib Treatment. |
Case Rep Oncol |
Bae SY, Ahn JS, Yang DH, Kim YK, Min JJ, Song HC, Bom HS, Jeong YY, Kim HJ, Lee JJ. |
4(1):101-5. |
|
